Sopharma AD (SPH) — Strategic Asset Allocation Index
Sopharma AD (SPH) has a Strategic Asset Allocation Index of 52.0% as of June 2023. Strategic assets (PP&E of zł370.19 Million plus long-term investments of zł-) total zł370.19 Million, measured against net assets of zł711.52 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Sopharma AD Strategic Asset Allocation Index (2017–2022)
This chart shows how Sopharma AD's Strategic Asset Allocation Index has evolved across 6 annual periods from 2017 to 2022. As of June 2023, the index stands at 52.0%, representing strategic assets of zł370.19 Million against net assets of zł711.52 Million PLN. Explore SPH cash flow metrics to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Sopharma AD (2017–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Sopharma AD from 2017 to 2022, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market value of Sopharma AD.
| Year | SAAI | Strategic Assets (PLN) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 52.4% | zł376.26 Million | zł376.26 Million | zł- | zł718.13 Million | ▼ -2.6 pp |
| 2021 | 55.0% | zł362.39 Million | zł362.39 Million | zł143.00 | zł658.87 Million | ▼ -14.9 pp |
| 2020 | 69.9% | zł395.87 Million | zł395.87 Million | zł149.00 | zł566.60 Million | ▲ +4.1 pp |
| 2019 | 65.8% | zł378.63 Million | zł378.62 Million | zł176.00 | zł575.77 Million | ▲ +1.9 pp |
| 2018 | 63.8% | zł324.53 Million | zł324.52 Million | zł62.00 | zł508.53 Million | ▲ +0.7 pp |
| 2017 | 63.1% | zł317.62 Million | zł317.62 Million | zł58.00 | zł503.11 Million | — |